Claritus Pharmaceuticals Inc. (CLAZF)

[StockWatch45]

Good Call. News within 1 day of your post.

Particularly liked this part:
Potential Out-License of GVHD Program to Corporate Partner
Kalytera is pursuing a corporate partnering strategy for its GVHD program, primarily because this could be a source of non-dilutive financing for the planned Phase 3 clinical study that will begin next year, as well as a source of potential revenues from up-front license fees, milestone payments and royalties. The Company is responding to due diligence requests from potential partners, and has engaged Echelon Wealth Partners to assist in managing this process.

To me, that last sentence makes something seem imminent - how long does the DD really take to complete?